These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2844937)

  • 1. Serum angiotensin-converting enzyme: an endothelial cell marker. Application to thromboembolic pathology.
    Drouet L; Baudin B; Baumann FC; Caen JP
    J Lab Clin Med; 1988 Oct; 112(4):450-7. PubMed ID: 2844937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids.
    Bénéteau-Burnat B; Baudin B
    Crit Rev Clin Lab Sci; 1991; 28(5-6):337-56. PubMed ID: 1663362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
    Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
    J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of serum angiotensin-converting enzyme before and after forearm venous stasis in diabetic microangiopathy.
    Porta M; Passera P; Bertagna A; La Selva M; Ricchetti I; Molinatti GM
    Diabetes Res; 1987 Mar; 4(3):117-20. PubMed ID: 3038452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells: target for the HIV1 virus?
    Drouet L; Scrobohaci ML; Janier M; Baudin B
    Nouv Rev Fr Hematol (1978); 1990; 32(1):103-6. PubMed ID: 1693419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
    Matucci-Cerinic M; Pignone A; Lotti T; Spillantini G; Curradi C; Leoncini G; Iannone F; Falcini F; Cagnoni M
    J Rheumatol; 1990 Mar; 17(3):328-30. PubMed ID: 2159071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and tissue angiotensin converting enzyme in patients with psoriasis.
    Huskić J; Mulabegović N; Alendar F; Ostojić L; Ostojić Z; Simić D; Milicević R; Naletilić M
    Coll Antropol; 2008 Dec; 32(4):1215-9. PubMed ID: 19149231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
    Wieczorek I; Ludlam CA; MacGregor IR
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme in pulmonary thromboembolism as a marker of vascular lesion].
    Muñoz Méndez J; Alfajeme Michavila I; Hernández Borge J; Martínez Muñoz I; Ortega Cuesta B; Alvarez-Sala Walther R; Sánchez Gascón F; Villamor León J
    Rev Clin Esp; 1997 Feb; 197(2):84-91. PubMed ID: 9213862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma markers of endothelial cells and platelet activation following handgrip in normals and hypertensive patients.
    Musumeci V; Cardillo C; Baroni S; Tutinelli F; Guerrera G; Melina D; Savi L; Folli G
    J Clin Hypertens; 1987 Dec; 3(4):487-99. PubMed ID: 2839626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.